''One size fits all'' unique drug to eradicate multiple viral species simultaneously from the central nervous system of co-infected individuals

Project description

Development of universal drug to target viral co-infection in the nervous system

Fields of science

• natural sciences › biological sciences › neurobiology
• medical and health sciences › basic medicine › pharmacology and pharmacy › drug discovery
• natural sciences › biological sciences › microbiology › virology
• medical and health sciences › health sciences › infectious diseases › RNA viruses › HIV
• medical and health sciences › basic medicine › neurology

Programme(s)

• H2020-EU.1.2. - EXCELLENT SCIENCE - Future and Emerging Technologies (FET) Main Programme
• H2020-EU.1.2.1. - FET Open

Topic(s)

• FETOPEN-01-2018-2019-2020 - FET-Open Challenging Current Thinking

Call for proposal

H2020-FETOPEN-2018-2020

See other projects for this call

Sub call

H2020-FETOPEN-2018-2019-2020-01

Funding Scheme

RIA - Research and Innovation action

Coordinator

INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES

Net EU contribution

€ 2 113 125,00

Address

Avenida Prof Egas Moniz
1649 028 Lisboa
Portugal

Region

Continente › Área Metropolitana de Lisboa › Área Metropolitana de Lisboa

Activity type

Research Organisations

Links

Non-EU contribution

€ 0,00

Participants (2)

UNIVERSIDAD POMPEU FABRA

Spain

Net EU contribution

€ 1 272 840,63

Address

Placa De La Merce, 10-12
08002 Barcelona

Region

Este › Cataluña › Barcelona

Activity type

Higher or Secondary Education Establishments

Links

Non-EU contribution

€ 0,00

SYNOVO GMBH

Germany

Net EU contribution

€ 548 000,00

Address

Paul Ehrlich Str 15
72076 Tuebingen

SME

The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.

Yes

Region

Baden-Württemberg › Tübingen › Tübingen, Landkreis

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

Links

Non-EU contribution

€ 0,00